Axim Biotechnologies Inc (AXIM): Huge signal from FDA on cannabinoid huma...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Thursday, 08/13/2020 12:07:37 AM

Thursday, August 13, 2020 12:07:37 AM

Huge signal from FDA on cannabinoid human trial to be sanctioned by FDA for the treatment of Alzheimer’s

This is fabulous news for the space

Axim

Keep Last Read

Next 10 Prev Next

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM

InvestorsHub NewsWire

Only $200 per official company press release!